Clinical Pharmacists Role in the Management of Hypertension in Jordan
1 other identifier
interventional
266
1 country
1
Brief Summary
Background: studies have demonstrated the crucial role of clinical pharmacists as integrated part of heath care team. Not only in Jordan but also in the Middle East region, clinical pharmacy practice is not well established. This current study is the first to evaluate physicians - pharmacists' collaborative approach to uncontrolled blood pressure in Jordan and the Middle East.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hypertension
Started Mar 2009
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2009
CompletedFirst Submitted
Initial submission to the registry
March 2, 2010
CompletedFirst Posted
Study publicly available on registry
March 3, 2010
CompletedApril 7, 2010
March 1, 2009
8 months
March 2, 2010
April 6, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
percentage of patients who achieved blood pressure goals specified by the JNC VII at each group
defined a goal to be achieved if the systolic blood pressure fell below 140 mm Hg and the diastolic blood pressure fell below 90 mm Hg. Or systolic blood pressure fell below 130 mm Hg and the diastolic blood pressure fell below 80 mm Hg if patient was diabetic.
6 month
Secondary Outcomes (1)
mean reductions in both systolic and diastolic blood pressure readings
6 months
Study Arms (2)
intervention group
ACTIVE COMPARATORphysician-pharmacist teamwork
control
NO INTERVENTIONphysician only team
Interventions
Patients treatment related problems and therapeutic needs or complains identified by clinical pharmacist and managed collaboratively by both pharmacist and the physician.
Eligibility Criteria
You may qualify if:
- Patients with uncontrolled BP, receiving 0-3 antihypertensive drugs with no change in the regimen or dose within the past 3 month.
You may not qualify if:
- Patients with hypertensive urgency or emergency with BP more than (180/110).
- Patients with recent stroke or myocardial infraction (within past 6 months).
- Patients with Class III or IV Chronic heart Failure (CHF).
- Patients with Unstable angina.
- Patients with Serious renal or hepatic disease.
- Pregnant patients.
- Patients with Dementia or cognitive impairment.
- If the patient is unable to provide informed written consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Jordanlead
- Jordan Hospitalcollaborator
Study Sites (1)
family medicine clinic JUH
Amman, 13046, Jordan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eman Hammad, MSc
University of Jordan/ Faculty of Pharmacy
- STUDY DIRECTOR
Abla Al bsoul, PhD
University of Jordan/ Faculty of Pharmacy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 2, 2010
First Posted
March 3, 2010
Study Start
March 1, 2009
Primary Completion
November 1, 2009
Study Completion
November 1, 2009
Last Updated
April 7, 2010
Record last verified: 2009-03